Evidence map›Paper›PMID 38294234›Full record

ReviewEcoSal Plus2024

Type IV pili of

Janay I Little, Pradip K Singh, Jinlei Zhao, Shakeera Dunn, Hanover Matz, Michael S Donnenberg

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in EcoSal Plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Janay I LittleSchool of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0002-7174-5742
Pradip K SinghSchool of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0003-0551-6877
Jinlei ZhaoSchool of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
Shakeera DunnInternal Medicine Residency, Bayhealth Medical Center, Dover, Delaware, USA.
Hanover MatzPathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Michael S DonnenbergSchool of Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0002-8818-3184

Funding

Progress In Understanding Type IV Pilus BiogenesisR56AI111767 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DONNENBERG, MICHAEL S · 2015 to 2015
$455k
Secretin ArchitectureR21AI123964 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI DONNENBERG, MICHAEL S · 2016 to 2017
$431k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R56AI111767, R21AI123964NIAID NIH HHS R21 AI123964NIAID NIH HHS R56 AI111767
6 · The paper itself

Abstract

Type IV pili (T4Ps) are surface filaments widely distributed among bacteria and archaea. T4Ps are involved in many cellular functions and contribute to virulence in some species of bacteria. Due to the diversity of T4Ps, different properties have been observed for homologous proteins that make up T4Ps in various organisms. In this review, we highlight the essential components of T4Ps, their functions, and similarities to related systems. We emphasize the unique T4Ps of enteric pathogens within the

Indexed as

EnterobacteriaceaeFimbriae, BacterialBacterial ProteinsFimbriae ProteinsHumansSalmonellaVirulenceBacterial ProteinsFimbriae Proteinsbundle-forming pilusColonization Factor Citrobactercolonization factor IIILongus pilustransfer T4Ptype IV pili

Identifiers

PMID38294234
PMCPMC11636386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.